Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination to prevent serious respiratory tract infection and COVID-19 in vulnerable older adults
NL-OMON49683Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial in coronavirus disease 2019 (COVID-19) and Airways Infection comparing BCG vaccine with Placebo (2 arms). Primary endpoints: Adaptive primary endpoint: clinically relevant respiratory tract infections requiring medical intervention and Adaptive primary endpoint: laboratory-confirmed and/or physician-diagnosed COVID-19. Started Sep 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)Airways Infection
Beyond the preview
Go deeper on NL-OMON49683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49683.